Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Virginia by County

Non-Hodgkin Lymphoma (Late Stage^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


Virginia6


US (SEER+NPCR)1


Staunton City6


Waynesboro City6


Nelson County6


Harrisonburg City6


Greene County6


Gloucester County6


Rockbridge County6


Northampton County6


Roanoke County6


Augusta County6


Charlottesville City6


Colonial Heights City6


Virginia Beach City6


Page County6


Bedford City and County6


Franklin County6


Rockingham County6


Orange County6


Roanoke City6


Culpeper County6


New Kent County6


Albemarle County6


Lynchburg City6


Washington County6


Fredericksburg City6


Goochland County6


King George County6


James City County6


Hanover County6


Newport News City6


Henry County6


Dinwiddie County6


Carroll County6


Southampton County6


Henrico County6


Amherst County6


Isle of Wight County6


Winchester City6


Norfolk City6


Brunswick County6


Chesapeake City6


Manassas City6


Chesterfield County6


Hopewell City6


Caroline County6


Spotsylvania County6


Prince George County6


Shenandoah County6


Portsmouth City6


Wythe County6


Hampton City6


Westmoreland County6


Stafford County6


Powhatan County6


Campbell County6


Arlington County6


Suffolk City6


Danville City6


Fauquier County6


Fluvanna County6


Pittsylvania County6


Warren County6


Patrick County6


Halifax County with South Boston City6


Richmond City6


York County6


Prince William County6


Mecklenburg County6


Tazewell County6


Russell County6


Montgomery County6


Fairfax County6


Accomack County6


Pulaski County6


Frederick County6


Louisa County6


Loudoun County6


Alexandria City6


Wise County6


Botetourt County6


Alleghany County and Clifton Forge City6 Amelia County6 Appomattox County6 Bath County6 Bland County6 Bristol City6 Buchanan County6 Buckingham County6 Buena Vista City6 Charles City County6 Charlotte County6 Clarke County6 Covington City6 Craig County6 Cumberland County6 Dickenson County6 Emporia City6 Essex County6 Fairfax City6 Falls Church City6 Floyd County6 Franklin City6 Galax City6 Giles County6 Grayson County6 Greensville County6 Highland County6 King William County6 King and Queen County6 Lancaster County6 Lee County6 Lexington City6 Lunenburg County6 Madison County6 Manassas Park City6 Martinsville City6 Mathews County6 Middlesex County6 Northumberland County6 Norton City6 Nottoway County6 Petersburg City6 Poquoson City6 Prince Edward County6 Radford City6 Rappahannock County6 Richmond County6 Salem City6 Scott County6 Smyth County6 Surry County6 Sussex County6 Williamsburg City6

Notes:
Created by statecancerprofiles.cancer.gov on 08/12/2022 7:05 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.